Axalbion
PrivateLast Round
Early Funding
Aug 27, 2024
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Axalbion is a clinical-stage biopharmaceutical company developing novel medicines for the treatment of chronic cough.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Axalbion Comparables
Compare Axalbion with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NeRRe Therapeutics | 86% | |
| Seyltx, Inc. | 84% | |
| Nocion Therapeutics | 80% |
Axalbion Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Aug 27, 2024 |
Axalbion Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Perscitus LLP | Early Funding |
| EPFL Innovation Park | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 54% MoM.
- Jul 26, 2026
Monthly visitors grew 309% MoM, reaching 2K.
Recent news
Latest coverage and updates
- hiresJul 1, 2026
Axalbion was planning to hire Stephanie as Chief Executive Officer and Director on Jul 1st '26.
- hiresJul 1, 2026
Axalbion hired Stephanie Read as Chief Executive Officer and Director on Jul 1st '26.
Axalbion Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Axalbion's valuation, stock price, and market status.
Is Axalbion a public or private company?
Axalbion is a private company.
What is the current stock price of Axalbion?
Axalbion is a private company with no public stock price. No recent secondary market data is available.
How much is Axalbion worth (valuation)?
Valuation information for Axalbion is not publicly available.
Can I buy Axalbion stock?
Axalbion shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Axalbion's last funding round?
Axalbion's most recent funding round was Early Funding on August 27, 2024.
Who are the main investors in Axalbion?
Key investors in Axalbion include Perscitus LLP, EPFL Innovation Park.
Will Axalbion IPO soon?
No public IPO plans have been announced for Axalbion.
How can I track Axalbion secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Axalbion's secondary market activity and sign up for updates.